Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lieberman

Showing results (341-350 of 345) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 345 results.
Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.
Cancer Research Communications|July 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine GlioblastomaMichal Nisnboym, Sarah R Vincze, Zujian Xiong, et al.
Nature Communications|January 21, 2021
Author Correction: Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrityH S Grantham, A Duncan, T D Evans, et al.
Nature Communications|December 9, 2020
Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrityH S Grantham, A Duncan, T D Evans, et al.
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Pageof 35

Showing results (341-350 of 345) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 345 results.
Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.
Cancer Research Communications|July 10, 2023
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine GlioblastomaMichal Nisnboym, Sarah R Vincze, Zujian Xiong, et al.
Nature Communications|January 21, 2021
Author Correction: Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrityH S Grantham, A Duncan, T D Evans, et al.
Nature Communications|December 9, 2020
Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrityH S Grantham, A Duncan, T D Evans, et al.
Cell Reports|December 19, 2023
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline gliomaStephanie M Casillo, Taylor A Gatesman, Akanksha Chilukuri, et al.
Pageof 35